Digitalis receptors in cardiac cells and their relation with positive inotropic and cardiotoxic effects

European Heart Journal
|December 1, 1984
PubMed

Insights

Ouabain

Area of Science:

  • Cardiovascular Physiology
  • Cellular Pharmacology
  • Biochemistry

Background:

  • The cardiac sodium-potassium adenosine triphosphatase ((Na+,K+)ATPase) is a key regulator of intracellular ion concentrations.
  • Ouabain is a cardiac glycoside known to interact with (Na+,K+)ATPase, but its precise mechanisms of action at different concentrations are not fully elucidated.

Purpose of the Study:

  • To investigate the biochemical and pharmacological properties of (Na+,K+)ATPase in chick embryonic hearts.
  • To determine the relationship between ouabain binding affinity, ion transport, and cardiotonic/cardiotoxic effects.

Main Methods:

  • Studied intact chick embryonic hearts and cultured cardiac cells.
  • Assessed ouabain binding sites, 86Rb+ uptake, intracellular Na+ concentration, and 45Ca2+ uptake.
  • Evaluated inotropic effects of ouabain on papillary muscle and ventricular cells.

Main Results:

  • Identified two ouabain binding sites: low affinity (2-6 microM) and high affinity (26-48 nM).
  • Low affinity site saturation correlated with (Na+,K+)ATPase inhibition, increased intracellular Na+, and stimulated Ca2+ uptake via Na+/Ca2+ exchange.
  • Cardiotonic effects of ouabain paralleled low affinity site saturation.

Conclusions:

  • Inhibition of cardiac (Na+,K+)ATPase at low affinity binding sites mediates both the beneficial cardiotonic and detrimental cardiotoxic effects of ouabain.
  • The Na+/Ca2+ exchange system plays a crucial role in ouabain's indirect effects on intracellular calcium.

Related Concept Videos

Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.2K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
2.3K
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
2.0K
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
11.8K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
645
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790